Ineos has completed a major £30 million investment at its Hull manufacturing site, converting the facility to run on clean-burning hydrogen instead of natural gas. This results in a 75% cut in carbon emissions.
The pharmaceutical service provider Siegfried has announced changes to its management team. Marianne Späne, who has been with the Swiss CDMO since 2004 and has held the position of Chief Business Officer since the beginning of 2020, is moving to the Board of Directors of the subsidiary Dinamiqs.
LBB Specialties (LBBS) recently announced the expansion of its distribution partnership with Clariant. This enhances LBBS’s presence in Puerto Rico, providing customers with access to pharmaceutical-grade excipients.
Bayer's Supervisory Board has unanimously decided to extend the contract with the company's CEO, Bill Anderson, until March 31, 2029.
Biobased feedstocks, enabled by catalyst innovation, are helping to defossilize chemical production and build a more sustainable industrial future.
Thorsten Dreier will remain Covestro's Chief Technology Officer for another five years. The Supervisory Board has extended his contract until June 30, 2031.
The Flamma Group, a Contract Development and Manufacturing Organization (CDMO), recently celebrated the grand opening of a new cGMP plant in Dalian, China.
IMCD recently appointed Andreas Igerl as Regional President EMEA and as Leader of the global Industrial Business Groups, and Narendra Varde as Regional President APAC.
Qore, a joint venture of Minnesota-based Cargill and Germany-based Helm, is officially starting production of Qira, the world’s first large-scale 1,4-butanediol (BDO) made from locally grown dent corn.
The start-up from Congo developed an organic absorbent fibre from a local invasive plant, the water hyacinth, to clean up oil spills.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.
Arkema is building an additional unit at its Singapore site to produce Rilsan Clear, a transparent polyamide. With an investment of $20 million, the site is expected to open in early 2026.
In a new building at the Wacker Consortium, the company's central research site, researchers are working on new manufacturing processes for biopharmaceuticals and ingredients for food and nutritional supplements.
Today, leading chemistry entrepreneurs from across Europe announced the founding of a new Industrial Green Chemistry Association dedicated to represent the interests of chemistry startups and innovation-driven SMEs.
IMCD recently announced the opening of its newly reorganised and expanded Life Science Laboratory hub in Shanghai.
Azelis has acquired Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic, and pharma industries in Italy.
The European Commission has launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030.
Bio-Rad Laboratories, a life science research and clinical diagnostics company, has completed the acquisition of Stilla Technologies, a developer of digital PCR (dPCR) systems.
Pace Life Sciences, a US-based contract research, development, and manufacturing organization (CRDMO), is remodeling and expanding its Salem, NH site for aseptic fill-finish processing.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
WeylChem Wesseling has announced its entry into the Advanced Materials market with the formation of a new Advanced Materials Business Line in Germany.
ENEOS and Mitsubishi Chemical have completed their chemical recycling facility at Mitsubishi Chemical’s Ibaraki Plant in Kamisu City, Ibaraki Prefecture, Japan.
Nippon Shokubai recently announced plans to expand its GMP-compliant manufacturing capacity for nucleic acid drug active pharmaceutical ingredients (APIs) tenfold.
CATL and its partners have started construction on a $6 billion battery integration project in West Java, Indonesia.
Hikma Pharmaceuticals USA announces $1 billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines.
The biopharmaceutical company Sanofi in Germany and the industrial park operator Infraserv Höchst laid the foundation stone for a state-of-the-art office building in the south of the industrial park.
AGC Biologics began its cell therapy process development and clinical manufacturing services on July 1, 2025, at its Yokohama Technical Center in Japan.
Peróxidos do Brasil, a joint venture between Solvay and Produtos Químicos Makay (PQM), announces a new strategic investment in its production unit in Chile.
With a modern laboratory, German adhesive tape technology specialist Tesa is laying the foundation for adhesive solutions of the future.
AbbVie has announced it will acquire Capstan Therapeutics, a clinical-stage biotechnology company focused on advancing in vivo cell engineering through RNA delivery using targeted lipid nanoparticles (tLNPs).
GenSight Biologics recently announced the successful transfer of the upstream phase of the manufacturing process for LUMEVOQ, the Company’s gene therapy candidate product to CDMO Catalent.
BASF has acquired DOMO Chemicals' 49% stake in the Alsachimie joint venture and is now the sole owner of the production company for essential precursors of polyamide (PA) 6.6, including KA oil, adipic acid and hexamethylenediamine adipate (AH salt) in Chalampé, France. The parties have agreed not to disclose financial details of the transaction.
Veranova appoints Matteo Villain as Vice President of Peptides and Oligonucleotides, strengthening its position as a key player in the Peptide and Oligonucleotide (TIDES) space.
Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.
